ANNX
Annexon, Inc.$5.52+0.10 (+1.94%)Prev Close$5.42·MCap$642.2M·P/E—·Vol2.25M·Yield—
▲
Buys (12M)
14
$12.35M
▼
Sells (12M)
8
$174.0K
◆
Net Activity
Net Buyer
$12.17M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Annexon, Inc. (ANNX) has been dominated by buying, with 14 insider purchases totaling $12.35M and 8 insider sales totaling $174.0K. The most recent insider transaction was by Satter Muneer A (director), who purchased $3.32M worth of shares on May 29, 2026. Annexon, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $642.2M.
ANNX Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Satter Muneer A | director | Buy | 613,497 | $5.41 | $3.32M0.5% OS | 10,342,134 |
| May 13, 2026 | Carson William H. | director | Buy | 8,000 | $5.78 | $46.2K | 78,405 |
| Apr 14, 2026 | Carson William H. | director | Buy | 8,000 | $6.20 | $49.6K | 70,405 |
| Mar 12, 2026 | Carson William H. | director | Buy | 8,000 | $5.67 | $45.4K | 62,405 |
| Feb 20, 2026 | Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | Sell | 5,290 | $5.10 | $27.0K | 73,152 |
| Feb 18, 2026 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | Sell | 5,290 | $5.10 | $27.0K | 0 |
| Feb 18, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 7,851 | $5.11 | $40.1K | 0 |
| Feb 18, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 6,225 | $5.10 | $31.7K | 0 |
| Feb 18, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 7,857 | $5.11 | $40.1K | 0 |
| Dec 30, 2025 | Carson William H. | Director | Buy | 4,115 | $5.02 | $20.7K | 0 |
| Dec 1, 2025 | Carson William H. | Director | Buy | 4,115 | $4.47 | $18.4K | 0 |
| Dec 1, 2025 | Choi Jung | Director | Buy | 33,000 | $4.19 | $138.3K | 0 |
| Nov 20, 2025 | Satter Muneer A | Director | Buy | 822,613 | $4.38 | $3.60M0.7% OS | 0 |
| Nov 17, 2025 | Satter Muneer A | Director | Buy | 1,500,000 | $3.37 | $5.05M1.3% OS | 0 |
| Oct 30, 2025 | Carson William H. | Director | Buy | 4,115 | $3.17 | $13.0K | 0 |
| Sep 30, 2025 | Carson William H. | Director | Buy | 4,115 | $3.05 | $12.6K | 0 |
| Sep 2, 2025 | Carson William H. | Director | Buy | 4,115 | $2.09 | $8.6K | 0 |
| Jul 30, 2025 | Carson William H. | Director | Buy | 4,115 | $2.43 | $10.0K | 0 |
| Jul 14, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 1,117 | $2.58 | $2.9K | 0 |
| Jul 14, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 853 | $2.61 | $2.2K | 0 |
| Jul 14, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 1,116 | $2.58 | $2.9K | 0 |
| Jun 30, 2025 | Carson William H. | Director | Buy | 4,115 | $2.46 | $10.1K | 0 |
| Feb 18, 2025 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | Sell | 5,515 | $2.97 | $16.4K | 0 |
| Feb 18, 2025 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sell | 5,521 | $2.96 | $16.3K | 0 |
| Feb 18, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 6,912 | $2.92 | $20.2K | 0 |
| Feb 18, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 6,618 | $2.95 | $19.5K | 0 |
| Feb 18, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 8,345 | $2.91 | $24.3K | 0 |
| Feb 13, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 1,786 | $2.98 | $5.3K | 0 |
| Feb 13, 2025 | Love Douglas | PRESIDENT AND CEO | Sell | 5,021 | $2.95 | $14.8K | 0 |
| Feb 13, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 1,425 | $2.99 | $4.3K | 0 |
| Feb 13, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 1,783 | $2.99 | $5.3K | 0 |
| Dec 2, 2024 | Carson William H. | Director | Buy | 3,200 | $5.33 | $17.1K | 0 |
| Oct 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 5,408 | $7.41 | $40.1K | 0 |
| Oct 1, 2024 | Carson William H. | Director | Buy | 3,200 | $5.97 | $19.1K | 0 |
| Sep 19, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 4,500 | $7.10 | $31.9K | 0 |
| Sep 12, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 5,500 | $6.16 | $33.9K | 0 |
| Sep 5, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 5,500 | $5.64 | $31.0K | 0 |
| Sep 3, 2024 | Carson William H. | Director | Buy | 3,200 | $5.48 | $17.5K | 0 |
| Aug 29, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 5,500 | $5.95 | $32.7K | 0 |
| Aug 1, 2024 | Carson William H. | Director | Buy | 3,200 | $6.24 | $20.0K | 0 |
| Jul 15, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 1,104 | $6.03 | $6.7K | 0 |
| Jul 15, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 784 | $6.02 | $4.7K | 0 |
| Jul 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 1,106 | $6.02 | $6.7K | 0 |
| Jul 1, 2024 | Carson William H. | Director | Buy | 3,200 | $5.00 | $16.0K | 0 |
| Jun 3, 2024 | Carson William H. | Director | Buy | 3,200 | $4.83 | $15.5K | 0 |
| May 1, 2024 | Carson William H. | Director | Buy | 3,200 | $4.68 | $15.0K | 0 |
| Apr 8, 2024 | Carson William H. | Director | Buy | 3,200 | $6.07 | $19.4K | 0 |
| Feb 16, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 2,593 | $5.53 | $14.3K | 0 |
| Feb 16, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 1,951 | $5.48 | $10.7K | 0 |
| Feb 16, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 2,604 | $5.51 | $14.3K | 0 |
Showing 1–50 of 75
1 / 2
ANNX Insider Buying Activity
The following table shows recent insider purchases of Annexon, Inc. (ANNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Satter Muneer A | director | Buy | 613,497 | $5.41 | $3.32M0.5% OS | 10,342,134 |
| May 13, 2026 | Carson William H. | director | Buy | 8,000 | $5.78 | $46.2K | 78,405 |
| Apr 14, 2026 | Carson William H. | director | Buy | 8,000 | $6.20 | $49.6K | 70,405 |
| Mar 12, 2026 | Carson William H. | director | Buy | 8,000 | $5.67 | $45.4K | 62,405 |
| Dec 30, 2025 | Carson William H. | Director | Buy | 4,115 | $5.02 | $20.7K | 0 |
| Dec 1, 2025 | Carson William H. | Director | Buy | 4,115 | $4.47 | $18.4K | 0 |
| Dec 1, 2025 | Choi Jung | Director | Buy | 33,000 | $4.19 | $138.3K | 0 |
| Nov 20, 2025 | Satter Muneer A | Director | Buy | 822,613 | $4.38 | $3.60M0.7% OS | 0 |
| Nov 17, 2025 | Satter Muneer A | Director | Buy | 1,500,000 | $3.37 | $5.05M1.3% OS | 0 |
| Oct 30, 2025 | Carson William H. | Director | Buy | 4,115 | $3.17 | $13.0K | 0 |
| Sep 30, 2025 | Carson William H. | Director | Buy | 4,115 | $3.05 | $12.6K | 0 |
| Sep 2, 2025 | Carson William H. | Director | Buy | 4,115 | $2.09 | $8.6K | 0 |
| Jul 30, 2025 | Carson William H. | Director | Buy | 4,115 | $2.43 | $10.0K | 0 |
| Jun 30, 2025 | Carson William H. | Director | Buy | 4,115 | $2.46 | $10.1K | 0 |
| Dec 2, 2024 | Carson William H. | Director | Buy | 3,200 | $5.33 | $17.1K | 0 |
| Oct 1, 2024 | Carson William H. | Director | Buy | 3,200 | $5.97 | $19.1K | 0 |
| Sep 3, 2024 | Carson William H. | Director | Buy | 3,200 | $5.48 | $17.5K | 0 |
| Aug 1, 2024 | Carson William H. | Director | Buy | 3,200 | $6.24 | $20.0K | 0 |
| Jul 1, 2024 | Carson William H. | Director | Buy | 3,200 | $5.00 | $16.0K | 0 |
| Jun 3, 2024 | Carson William H. | Director | Buy | 3,200 | $4.83 | $15.5K | 0 |
| May 1, 2024 | Carson William H. | Director | Buy | 3,200 | $4.68 | $15.0K | 0 |
| Apr 8, 2024 | Carson William H. | Director | Buy | 3,200 | $6.07 | $19.4K | 0 |
ANNX Insider Selling Activity
The following table shows recent insider sales of Annexon, Inc. (ANNX) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Dananberg Jamie | officer: CHIEF MEDICAL OFFICER | Sell | 5,290 | $5.10 | $27.0K | 73,152 |
| Feb 18, 2026 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | Sell | 5,290 | $5.10 | $27.0K | 0 |
| Feb 18, 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 7,851 | $5.11 | $40.1K | 0 |
| Feb 18, 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 6,225 | $5.10 | $31.7K | 0 |
| Feb 18, 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 7,857 | $5.11 | $40.1K | 0 |
| Jul 14, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 1,117 | $2.58 | $2.9K | 0 |
| Jul 14, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 853 | $2.61 | $2.2K | 0 |
| Jul 14, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 1,116 | $2.58 | $2.9K | 0 |
| Feb 18, 2025 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | Sell | 5,515 | $2.97 | $16.4K | 0 |
| Feb 18, 2025 | Dananberg Jamie | CHIEF MEDICAL OFFICER | Sell | 5,521 | $2.96 | $16.3K | 0 |
| Feb 18, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 6,912 | $2.92 | $20.2K | 0 |
| Feb 18, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 6,618 | $2.95 | $19.5K | 0 |
| Feb 18, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 8,345 | $2.91 | $24.3K | 0 |
| Feb 13, 2025 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 1,786 | $2.98 | $5.3K | 0 |
| Feb 13, 2025 | Love Douglas | PRESIDENT AND CEO | Sell | 5,021 | $2.95 | $14.8K | 0 |
| Feb 13, 2025 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 1,425 | $2.99 | $4.3K | 0 |
| Feb 13, 2025 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 1,783 | $2.99 | $5.3K | 0 |
| Oct 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 5,408 | $7.41 | $40.1K | 0 |
| Sep 19, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 4,500 | $7.10 | $31.9K | 0 |
| Sep 12, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 5,500 | $6.16 | $33.9K | 0 |
| Sep 5, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 5,500 | $5.64 | $31.0K | 0 |
| Aug 29, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 5,500 | $5.95 | $32.7K | 0 |
| Jul 15, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 1,104 | $6.03 | $6.7K | 0 |
| Jul 15, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 784 | $6.02 | $4.7K | 0 |
| Jul 15, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 1,106 | $6.02 | $6.7K | 0 |
| Feb 16, 2024 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sell | 2,593 | $5.53 | $14.3K | 0 |
| Feb 16, 2024 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | Sell | 1,951 | $5.48 | $10.7K | 0 |
| Feb 16, 2024 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sell | 2,604 | $5.51 | $14.3K | 0 |
ANNX Insiders
Similar Stocks to ANNX
VRTX
Vertex Pharmaceuticals Incorporated
$437.60-2.22%
$113.59B
REGN
Regeneron Pharmaceuticals, Inc.
$603.40-1.85%
$63.34B
ALNY
Alnylam Pharmaceuticals, Inc.
$300.51-0.45%
$40.32B
RVMD
Revolution Medicines, Inc.
$164.16+4.43%
$33.48B
UTHR
United Therapeutics Corporation
$546.63-1.83%
$23.64B
INSM
Insmed Incorporated
$105.67-1.21%
$23.17B
INCY
Incyte Corporation
$95.67-1.11%
$19.33B
MRNA
Moderna, Inc.
$46.29-1.95%
$18.72B